Detalhe da pesquisa
1.
Coordinating Cardiology clinics randomized trial of interventions to improve outcomes (COORDINATE) - Diabetes: rationale and design.
Am Heart J
; 256: 2-12, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36279931
2.
Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial.
JAMA
; 329(15): 1261-1270, 2023 04 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36877177
3.
Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community.
Circulation
; 144(1): 74-84, 2021 07 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34228476
4.
Inhibition of p38 MAP kinase in patients with ST-elevation myocardial infarction - findings from the LATITUDE-TIMI 60 trial.
Am Heart J
; 243: 147-157, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34508693
5.
Role of Primary Care Clinicians in the Management of Patients With Type 2 Diabetes and Cardiorenal Diseases.
Clin Diabetes
; 40(4): 401-412, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36381309
6.
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
Am J Kidney Dis
; 77(1): 94-109, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33121838
7.
Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data.
Cardiovasc Diabetol
; 20(1): 159, 2021 07 31.
Artigo
Inglês
| MEDLINE | ID: mdl-34332558
8.
Association of sodium-glucose cotransporter-2 inhibitors with outcomes in type 2 diabetes with reduced and preserved left ventricular ejection fraction: Analysis from the CVD-REAL 2 study.
Diabetes Obes Metab
; 23(6): 1431-1435, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33606906
9.
Emerging opportunities to harness real world data: An introduction to data sources, concepts, and applications.
Diabetes Obes Metab
; 22 Suppl 3: 3-12, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32250526
10.
Once-weekly semaglutide reduces the risk of cardiovascular events in people with type 2 diabetes and polyvascular disease: A post hoc analysis.
Diabetes Obes Metab
; 26(3): 1129-1132, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38082468
11.
Hypertension Treatment in Diabetes: Focus on Heart Failure Prevention.
Heart Fail Clin
; 15(4): 551-563, 2019 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-31472890
12.
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.
Circulation
; 136(9): 849-870, 2017 Aug 29.
Artigo
Inglês
| MEDLINE | ID: mdl-28847797
13.
Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care).
Circulation
; 135(20): 1911-1921, 2017 May 16.
Artigo
Inglês
| MEDLINE | ID: mdl-28246236
14.
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).
Circulation
; 136(3): 249-259, 2017 Jul 18.
Artigo
Inglês
| MEDLINE | ID: mdl-28522450
15.
Meta-analysis of transfemoral TAVR versus surgical aortic valve replacement.
Catheter Cardiovasc Interv
; 91(4): 806-812, 2018 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29068166
16.
Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study.
Diabetes Obes Metab
; 25(8): 2402-2409, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37055714
17.
Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study.
Diabetes Obes Metab
; 20(8): 1983-1987, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29569378
18.
Consistent Reduction in Periprocedural Myocardial Infarction With Cangrelor as Assessed by Multiple Definitions: Findings From CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition).
Circulation
; 134(10): 723-33, 2016 Sep 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27482008
19.
Blood pressure lowering in the prevention of type 2 diabetes.
Lancet
; 398(10313): 1778-1779, 2021 11 13.
Artigo
Inglês
| MEDLINE | ID: mdl-34774133
20.
Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
Circulation
; 132(10): 923-31, 2015 Sep 08.
Artigo
Inglês
| MEDLINE | ID: mdl-26152709